VEGFA and central nervous system cancer: The results demonstrated that 123I-VEGF uptake was highly specific to WHO grade IV gliomas: 14 of 16 patients with grade IV tumors showed significant uptake at 18 h, whereas no increased uptake was observed in patients with grade II or III tumors.